Laura Marconato, Head of Medical Oncology at University of Bologna, shared a post on LinkedIn about a recent article by Oluwaseun Ayoade et al, published in JAMA:
“A very important paper has just been published in JAMA, showing that human patients who use complementary or alternative medicine for cancer treatment (specifically here in breast cancer) have worse survival outcomes, even when these approaches are used alongside conventional therapy.
In my clinical experience, this trend is not limited to human medicine. We often observe similar patterns in veterinary oncology, where the use of unproven alternative therapies may delay or interfere with evidence-based treatment.
While the desire to explore all possible options is completely understandable, especially in the face of a cancer diagnosis, it is essential that treatment decisions remain grounded in scientific evidence.
This remains our primary responsibility.”
Title: Use of Complementary and Alternative Medicine in the Management of Breast Cancer
Authors: Oluwaseun Ayoade, Giorgio Caturegli, Maureen Canavan, Benjamin Resio, Elizabeth Berger, Daniel Boffa
Read the Full Article on JAMA
